✦ LIBER ✦

Interferon/pegylated interferon and ribavirin in HCV-associated kidney disease with or without cryoglobulinemia

✍ Scribed by A. Bruchfeld; K. Lindahl; L. Stahle; R. Schvarcz

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effectiveness of Pegylated Interferon an

✍ J.M. Moreno Planas; E. Rubio González; E. Boullosa Graña; M. Fernández Ruiz; M. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 49 KB

HCV treatment with pegylated interferon

✍ J. T. DENHOLM; E. J. WRIGHT; A. STREET; J. J. SASADEUSZ 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

Pegylated interferon and ribavirin assoc

✍ C. Burgueño-Montañés; R. Pérez-Álvarez 📂 Article 📅 2011 🏛 Elsevier ⚖ 308 KB

Efficacy and safety of treatment with pe

✍ C. Mazzaro; A.M. Baragiotta; G. Pozzato; G. Monti; D. Filippini; C. Donada; A. T 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Pegylated interferon and ribavirin treat

✍ Kevin Liebovich; Frank Iber; Rodney Tehrani; Aileen Pangan; Elaine Adams; Nikunj 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 24 KB

Early ribavirin pharmacokinetics, HCV RN

✍ Harel Dahari; Marianthi Markatou; Marija Zeremski; Ivan Haller; Ruy M. Ribeiro; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 243 KB